27 Aug 2024

06:39 PM EDT • Abbott • Abbott Receives U.S. FDA Clearance for Two New Over-the-Counter Continuous Glucose Monitoring Systems

06:23 PM EDT • CNBC • Dexcom launches first over-the-counter continuous glucose monitor.

06:20 PM EDT • CNET • Blood Sugar Tracking Heats Up: Dexcom's Over-the-Counter Sensor Now Available for Sale

05:20 PM EDT • CNBC • Eli Lilly launches a new, cheaper form of weight loss drug Zepbound for as low as $399 a month

08 Aug 2024

07:31 PM EDT • Nature Biotechnology • Biotech financing: darkest before the dawn

24 Jan 2024

12:00 AM EST • Investor's Business Daily • Is Gilead's 10% Crash — Resulting In A Failed Breakout — An Overreaction?

11:37 PM EST • YouTube • Gilead Lung Cancer Study Update #Gilead #lungcancer #clinicaltrial GILD

22 Jan 2024

10:01 AM EST • CNBC • Stock Price, Quote and News

09:52 AM EST • gilead • Gilead Provides Update on Phase 3 EVOKE-01 Study

18 Jan 2024

02:40 PM EST • YouTube • Healthcare Company Humana: A Quick Rant #healthcare #stockmarket $HUM

12:12 PM EST • CNBC • Humana warns higher medical costs may hit 2024 forecast

12:02 PM EST • MarketWatch • Humana’s stock tumbles as Medicare Advantage growth disappoints

10:18 PM EST • YouTube • Review of Pharma Company AbbVie: Part 2

10:09 PM EST • YouTube • Review of Pharma Company AbbVie Part 1

28 Nov 2022

01:08 PM EST • Science • As creator of ‘CRISPR babies’ nears release from prison, where does embryo editing stand?

01:02 PM EST • MIT Technology Review • The creator of the CRISPR babies has been released from a Chinese prison

12:48 PM EST • YouTube • He Jiankui and the World's First Gene-edited Babies

12:42 PM EST • South China Morning Post • He Jiankui, creator of world’s first gene-edited babies, seeks Chinese government funding for DNA synthesiser

12:17 PM EST • Pandaily • Chinese Gene-Editing Scientist He Jiankui Sets Up Beijing Lab Following Prison Release

21 Nov 2022

11:51 AM EST • China Daily • Beijing COVID cases continue to rise

11:43 AM EST • South China Morning Post • Coronavirus: Beijing moves teaching online, urges people to stay home while testing China’s shift from strict measures

11:39 AM EST • BBC • Beijing facing 'most severe Covid test' as China reports first deaths in six months

11:37 AM EST • CNN • Guangzhou Covid-19: China locks down key transportation hub; markets fear economic fallout

11:29 AM EST • CNBC • China reports first Covid deaths since May lockdown in Shanghai

11:10 AM EST • Endpoints News • Updated: No Seagen here: 'Do more' means a small $1.35B purchase of Imago for Merck

11:06 AM EST • YouTube • Merck to buy Imago BioSciences for $1.35 billion

11:04 AM EST • Reuters • Merck to buy Imago for $1.35 bln to broaden portfolio of blood disorder drugs

19 Nov 2022

11:41 AM EST • US FDA • FDA Approves First Drug That Can Delay Onset of Type 1 Diabetes

11:39 AM EST • BioPharma Dive • First-of-its-kind Type 1 diabetes drug wins FDA approval

11:33 AM EST • USA Today • FDA approves first treatment that delays Type 1 diabetes. Why it could be 'game changing'

10:43 AM EST • Vogue • Elizabeth Holmes Is Sentenced to More Than 11 Years in Jail

10:37 AM EST • CNN • Elizabeth Holmes sentenced to more than 11 years in prison for fraud

10:27 AM EST • New York Times • Elizabeth Holmes Is Sentenced to More Than 11 Years for Fraud

28 Sep 2022

05:31 PM EDT • Investor's Business Daily • Biogen Stock Explodes Higher After Alzheimer's Drug Succeeds In Final-Phase Test

05:04 PM EDT • New York Times • Alzheimer’s Drug Slows Cognitive Decline in Key Study

04:56 PM EDT • Reuters • Biogen shares soar on landmark Alzheimer's data, lift rivals

04:47 PM EDT • Biogen • LECANEMAB CONFIRMATORY PHASE 3 CLARITY AD STUDY MET PRIMARY ENDPOINT, SHOWING HIGHLY STATISTICALLY SIGNIFICANT REDUCTION OF CLINICAL DECLINE IN LARGE GLOBAL CLINICAL STUDY OF 1,795 PARTICIPANTS WITH E

26 Sep 2022

05:03 PM EDT • Genetic Engineering & Biotechnology News • Prime Medicines Files for IPO, Revealing 18-Program Pipeline and First Patent

04:53 PM EDT • Endpoints News • They’re going for it: David Liu’s preclinical biotech shoots for a (maybe $200M) IPO

04:47 PM EDT • US Securities and Exchange Commission - US SEC • Document

04:44 PM EDT • BioPharma Dive • Prime Medicine becomes the next high-profile biotech to test the IPO waters

21 Sep 2022

05:25 PM EDT • Endpoints News • Catalent’s Covid-19 vaccine manufacturing site hit with Form 483 over foreign objects in vials and other QC issues

05:11 PM EDT • Investor's Business Daily • Biotech Stocks Notch A Blazing Path In 2022 — Why The Good Times Aren't Over

15 Aug 2022

11:06 AM EDT • BioSpace • BrainStorm’s ALS Drug Heads to the FDA with Correction to Phase III Analyses

10:40 AM EDT • Nature • How does monkeypox spread? What scientists know

10:29 AM EDT • STAT • What scientists know — and don’t know — about how monkeypox spreads

09:45 AM EDT • The Jerusalem Post | JPost.com • COVID-19: Pfizer CEO Albert Bourla tests positive, has mild symptoms

27 May 2022

05:42 PM EDT • Reuters • EU in talks for common purchase of vaccine, antiviral against monkeypox

05:36 PM EDT • STAT • Health officials scramble to raise monkeypox awareness ahead of Pride Month

05:18 PM EDT • CDC • Monkeypox